日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls

血清蛋白生物标志物谱可区分乙酰胆碱受体抗体血清阳性的重症肌无力患者与健康对照者

Amol K Bhandage, Viktorija Kenina, Yu-Fang Huang, Marija Roddate, Gundega Kauke, Arta Grosmane, Violeta Žukova, Niclas Eriksson, Katja Gabrysch, Tanel Punga, Anna Rostedt Punga

Functional imaging of conduction dynamics in cortical and spinal axons

皮质和脊髓轴突传导动力学的功能成像

Milos Radivojevic, Anna Rostedt Punga

Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

重症肌无力的个性化医疗:循环微小 RNA miR-30e-5p、miR-150-5p 和 miR-21-5p 的作用

Francesca Beretta, Yu-Fang Huang, Anna Rostedt Punga

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs

雌激素受体、炎症和 FOXO 转录因子调节重症肌无力相关循环微小 RNA 的表达

Alyson A Fiorillo, Christopher R Heier, Yu-Fang Huang, Christopher B Tully, Tanel Punga, Anna Rostedt Punga

Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum

血浆中炎症和抗炎标志物:从妊娠晚期到产后早期

Bränn, Emma; Edvinsson, Åsa; Rostedt Punga, Anna; Sundström-Poromaa, Inger; Skalkidou, Alkistis

Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology

长期高密度细胞外记录助力肌肉细胞生理学研究

Marta K Lewandowska, Evgenii Bogatikov, Andreas R Hierlemann, Anna Rostedt Punga

How clinical trials of myasthenia gravis can inform pre-clinical drug development

重症肌无力临床试验如何为临床前药物研发提供信息

Rostedt Punga, Anna; Kaminski, Henry J; Richman, David P; Benatar, Michael

Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS

重症肌无力小鼠模型中的疲劳和肌肉萎缩与肌膜 nNOS 的丧失同时存在

Sarina Meinen, Shuo Lin, Markus A Rüegg, Anna Rostedt Punga